StockData

Zoar Ltd (ZOAR) stock

ZOARPharmaceutical PreparationsFiscal year ends March 31
$4.36−2.03 (-31.77%)

Close on Nov 19, 2026Market cap –P/E –Yield –

Earnings

Zoar's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Zoar's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Zoar has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Zoar puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Zoar filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?